Coronary Artery Disease: Clinical Trials

4,750 trials for Coronary Artery Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2512 completed, 933 unknown, 465 recruiting, 265 terminated. 1723 Not applicable, 645 Phase 4, 319 Phase 3, 299 Phase 2, 119 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1723Completed 859, Unknown 317, Recruiting 177, Not yet recruiting 123, Terminated 97, Active not recruiting 90, Withdrawn 45, Enrolling by invitation 11, Suspended 4
Phase 4645Completed 361, Unknown 154, Terminated 52, Recruiting 38, Withdrawn 18, Active not recruiting 11, Not yet recruiting 10, Suspended 1
Phase 3319Completed 205, Unknown 50, Terminated 29, Recruiting 14, Active not recruiting 7, Withdrawn 7, Not yet recruiting 4, Suspended 2, Enrolling by invitation 1
Phase 2299Completed 198, Unknown 51, Recruiting 18, Terminated 16, Not yet recruiting 7, Withdrawn 6, Active not recruiting 2, Suspended 1
Phase 1119Completed 83, Unknown 14, Terminated 10, Withdrawn 6, Recruiting 4, Not yet recruiting 2
Early Phase 117Completed 11, Unknown 2, Withdrawn 2, Enrolling by invitation 1, Terminated 1

Follow Coronary Artery Disease: new trials by email Literature Review of Coronary Artery Disease trials Research Report on Coronary Artery Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Clinical Decision Aid, Standard Care - Heart Failure, Coronary Artery Disease
Not yet recruitingMedical College of Wisconsin602027-12-012026-11-03
Needle Free Assessment of Myocardial Oxygenation in Healthy Subjects
RespirAct - Coronary Artery Disease
Not applicableNot yet recruitingIndiana University802027-11-012026-10-26
Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease
Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141) - low dose, Human Recombinant Fibroblast Growth Factor-1 (FGF1-141) - high dose, Placebo - Coronary Disease, Coronary Heart Disease
Phase 2Not yet recruitingVenturis Therapeutics, Inc.1502027-09-012026-08-19
Heart tEam Decision-making Assisted by Revaz AI Trial
Revaz AI - Coronary Artery Disease
Not applicableNot yet recruitingUniversity of Calgary7122027-04-012026-09-24
OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation
Oral anticoagulation, Single antiplatelet therapy - Atrial Fibrillation (AF), Coronary Artery Disease
Phase 4Not yet recruitingEwha Womans University Mokdong Hospital22027-03-012026-03-27
A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma
Evolocumab, Routine Lipid Management, Autoinjector - Coronary Artery Disease, Hypercholesterolemia
Phase 4Not yet recruitingAmgen3082027-01-312026-09-21
Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease
RespirAct - Coronary Artery Disease
Not applicableNot yet recruitingIndiana University302027-01-102026-05-26
Nursing Intervention for Adaptation After Myocardial Revascularization
Nursing Intervention Program, Usual Care - Coronary Artery Disease, Myocardial Revascularization
Not applicableNot yet recruitingUniversidad de la Sabana402027-01-012026-05-08
Photobiomodulation in Coronary Artery Bypass Grafting With No-Touch vs Conventional Saphenous Vein Harvesting.
Photobiomodulation Therapy, Sham Laser irradiation, Conventional Saphenous Vein Harvesting - Coronary Artery Disease, Coronary Artery Bypass Graft (CABG)
Not applicableNot yet recruitingFederal University of São Paulo2922027-01-012026-10-07
Intraoperative Ultrasound Assessment of Coronary Artery and Bypass Graft Blood Flow During CABG
Intraoperative Ultrasound Blood Flow Measurement - Coronary Artery Disease
Not yet recruitingThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1902027-01-012026-08-11
wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65
Arm 1: wCAR-CARE - Precision Prevention (Arm A), Guideline-directed standard of care - Cardiovascular Diseases (CVD), Coronary Artery Disease
Not applicableNot yet recruitingWomen's Heart Austria8002027-01-012026-09-30
Modified Jailed Balloon Technique vs Jailed Wire Technique in Coronary Bifurcation Intervention
jailed wire technique, Modified jailed balloon technique - Coronary Artery Disease
Not applicableNot yet recruitingAssiut University1402027-01-012026-10-14
Rapid Inflation/Deflation Compared With Prolonged High-Pressure Balloon Inflation
Prolonged inflation, Rapid inflation - Coronary Artery Disease, Coronary Stent Occlusion
Not applicableNot yet recruitingCentral Arkansas Veterans Healthcare System402027-01-012026-10-21
Assessment of Transnational Performance of the Universal Cardiac Surgical Risk Score Across International Sites
Risk score calculation - Heart Valve Diseases, Cardiac Surgical Procedures
Not yet recruitingUnion Health System50002027-01-012026-11-05
The CORE Platform Trial
MIDCAB procedure, CABG procedure - Coronary Revascularization, Coronary Artery Disease
Not applicableNot yet recruitingCopenhagen Trial Unit, Center for Clinical Intervention Research150002027-01-012026-10-27
Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCI
Empagliflozin (SGLT2i), dapagliflozin, Standard medical treatment - No Reflow Phenomenon, Reperfusion Injuries, Myocardial
Phase 2Not yet recruitingAl-Azhar University1002027-01-012026-10-27
Health Coaching for Patients With Cardiovascular Disease
Health Coaching - Congestive Heart Failure Treated, Myocardial Infarction (MI)
Not applicableNot yet recruitingOhio State University702027-01-012026-11-12
PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF
Percutaneous coronary intervention, Guideline-directed medical therapy - Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease
Not applicableNot yet recruitingNanjing First Hospital, Nanjing Medical University11542026-12-302026-05-28
PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulnerable Plaque Evaluated by CoroNary Computed Tomography Angiography-2
Initial Invasive Strategy, Initial Conservative Strategy - Coronary Artery Disease
Not applicableNot yet recruitingDuk-Woo Park, MD25002026-12-302026-10-21
Clinical Evidence With Biomarker Confirmation for PPMI in PCI Clinical Trials Study
Biomarker testing - Peri-procedural Myocardial Infarction, Heart Failure Hospitalization
Not yet recruitingBaim Institute for Clinical Research10002026-12-012026-09-30

Showing 20 of 4750. Sign in to see all of them.

Narrower conditions

Myocardial Ischemia (381)  ·  Cardiovascular Diseases (334)  ·  Coronary Disease (304)  ·  Myocardial Infarction (304)  ·  Atherosclerosis (268)  ·  Acute Coronary Syndrome (222)  ·  Heart Diseases (217)  ·  Angina Pectoris (192)  ·  Diabetes Mellitus (192)  ·  Coronary Stenosis (176)  ·  Heart Failure (137)  ·  Angina, Stable (114)  ·  Diabetes Mellitus, Type 2 (108)  ·  Hypertension (90)

Broader conditions

Arterial Occlusive Diseases (4684)  ·  Arteriosclerosis (4679)  ·  Vascular Diseases (4664)  ·  Heart Diseases (4533)  ·  Coronary Disease (4446)  ·  Cardiovascular Diseases (4416)  ·  Myocardial Ischemia (4369)  ·  Pathological Conditions, Signs and Symptoms (1149)  ·  Pathologic Processes (807)  ·  Signs and Symptoms (485)  ·  Nutritional and Metabolic Diseases (424)  ·  Neurologic Manifestations (423)  ·  Metabolic Diseases (407)  ·  Necrosis (388)  ·  Pain (386)

Interventions

Clopidogrel (166)  ·  Percutaneous Coronary Intervention (157)  ·  Aspirin (120)  ·  Ticagrelor (99)  ·  Prasugrel Hydrochloride (60)  ·  Atorvastatin (55)  ·  Drug-Eluting Stents (48)  ·  Coronary Artery Bypass (44)  ·  Rosuvastatin Calcium (44)  ·  Exercise (41)  ·  regadenoson (33)  ·  Stents (28)  ·  Tomography, Optical Coherence (28)  ·  Ezetimibe (25)  ·  Colchicine (23)

Sponsors

Abbott Medical Devices (79)  ·  Yonsei University (61)  ·  Seung-Jung Park (58)  ·  China National Center for Cardiovascular Diseases (55)  ·  National Heart, Lung, and Blood Institute (NHLBI) (48)  ·  Boston Scientific Corporation (46)  ·  Seoul National University Hospital (44)  ·  Cordis US Corp. (41)  ·  University of Florida (39)  ·  Ottawa Heart Institute Research Corporation (38)  ·  Medtronic Vascular (34)  ·  Fundación EPIC (33)  ·  Insel Gruppe AG, University Hospital Bern (33)  ·  Samsung Medical Center (30)  ·  University of Roma La Sapienza (29)

Countries

United States (1089)  ·  China (522)  ·  Germany (353)  ·  South Korea (352)  ·  Italy (293)  ·  United Kingdom (280)  ·  Netherlands (275)  ·  Canada (267)  ·  France (214)  ·  Spain (203)  ·  Belgium (184)  ·  Denmark (181)  ·  Switzerland (175)  ·  Brazil (150)  ·  Poland (146)

Top investigators

Seung-Jung Park, MD, PhD (31)  ·  Bon-Kwon Koo, MD, PhD (18)  ·  Gregg W Stone, MD (11)  ·  Dominick J Angiolillo, MD, PhD (10)  ·  Ron Waksman, MD (10)  ·  Shao-Liang Chen, MD (10)  ·  Shigeru Saito, MD (10)  ·  Adnan Kastrati, MD (9)  ·  Antonio Colombo, MD (9)  ·  David Kandzari, MD (9)  ·  Gilbert Raff, MD (8)  ·  Alexander Ehlgen, MD, PhD (7)  ·  Dominick Angiolillo, MD, PhD (7)  ·  Emmanouil S Brilakis, MD, PhD (7)

Results publications

PMID 35224730, PMID 40875095, PMID 25940520, PMID 24746650, PMID 19463432, PMID 20142198, PMID 23468513, PMID 23523454, PMID 30165437, PMID 17296825, PMID 23232250, PMID 24510638, PMID 26825231, PMID 29089314, PMID 31561250, PMID 32227755, PMID 32890442, PMID 33939604, PMID 34056911, PMID 35641327, PMID 37256598, PMID 37619976, PMID 37745109, PMID 40590244, PMID 41913985, PMID 17132052, PMID 17145250, PMID 17982182, PMID 18765162, PMID 19228612, PMID 19717846, PMID 20129555, PMID 21232717, PMID 21670242, PMID 22017936, PMID 22032711, PMID 22070834, PMID 22115661, PMID 25173339, PMID 25176289, PMID 25593120, PMID 25825008, PMID 26585622, PMID 28317458, PMID 28495897, PMID 29217001, PMID 29891620, PMID 30475845, PMID 30586701, PMID 32295417

NIH funding

2017 (7), 2023 (7), 2025 (6), 2018 (5), 2016 (4), U01HL088942 (4), 2014 (3), 2015 (3), 2019 (3), 2009 (2), K23HL105897 (2), P50HL110789 (2), R01AG031750 (2), R01HL092954 (2), R01HL142297 (2)